Average Co-Inventor Count = 5.52
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (15 from 2,405 patents)
2. Pionyr Immunotherapeutics, Inc. (3 from 5 patents)
3. Bristol-myers Squibb Compnay (2 from 3,685 patents)
4. Ambrx, Inc. (2 from 113 patents)
5. Five Prime Therapeutics, Inc. (2 from 72 patents)
6. Portsmouth Merger Sub Ii, LLC (1 from 2 patents)
21 patents:
1. 12435136 - Antibodies binding to ILT4
2. 12378311 - Anti-MARCO antibodies and uses thereof
3. 12102681 - Anti-LAG3 antibodies and antigen-binding fragments
4. 12102680 - Anti-TIGIT antibodies
5. 12065491 - Anti-TREM1 antibodies and related methods
6. 11958902 - Anti-TIGIT antibodies
7. 11572407 - Anti-MARCO antibodies and uses thereof
8. 11510993 - Antibody drug conjugate for anti-inflammatory applications
9. 11401328 - Antibodies binding to ILT4
10. 11278620 - Anti-LAG3 antibodies and antigen-binding fragments
11. 11207406 - Anti-LAG3 antibodies and antigen-binding fragments
12. 11045547 - Anti-LAG3 antibodies and antigen-binding fragments
13. 10898571 - Anti-LAG3 antibodies and antigen-binding fragments
14. 10836828 - Anti-TREM1 antibodies and related methods
15. 10766957 - Anti-TIGIT antibodies